What are the opening hours?

Monday 9am - 5pm Tuesday 9am - 5pm Wednesday 9am - 5pm Thursday 9am - 5pm Friday 9am - 5pm Saturday 9am - 5pm Sunday 9am - 5pm

International Society for the Study of Xenobiotics

Home
United States
Washington D.C., DC
International Society for the Study of Xenobiotics

Directions Website

ISSX advances research and education on the interplay of living systems with medicines and chemicals for the benefit of society worldwide. Who Is ISSX?

ISSX has an international base of members from more than 45 countries. Members are comprised fairly evenly between academic and industry groups and consist primarily of research scientists and future scientists in toxicology, pharmacology, molecular biology, and other disciplines related to the study of xenobiotics. What Does ISSX Do? As the foremost organization representing the interests of researchers and educators in the field of xenobiotics, the Society is engaged in multiple activities to support, promote, and advance the profession on a global scale. ISSX:

Hosts the International Meeting, one of the world’s largest gatherings of researchers in xenobiotics, offering innovative short courses, symposia, lectures and other events. Hosts regional meetings and workshops in Asia-Pacific, Europe, and North America on a regular basis. Awards recognition of excellence in scientific and service achievements through the international Distinguished Scientific Achievement and Distinguished Service Awards, and the regional Scientific and New Investigator Awards. Offers opportunities for professional exposure through solicitation and publication of abstracts and poster presentations.

10/09/2026

We are excited to host 11 different thought leaders throughout the meeting to share quick and topical insights worth sharing. We look forward to seeing you there!
📆See the meeting program for more details about the Thought Leader Presentation schedule: issxmeetings.org/2026-na/meeting-program

09/25/2026

ISSX Africa: Transforming Science, Connecting Worlds was recognized last night with the American Society of Association Executives' 2026 Power of Associations Summit Award, the highest honor presented by ASAE. This award recognizes the Society's work to expand engagement in pharmacogenomics and DMPK across Africa.

The award was presented to Julius Enoru, Co-Chair of the ISSX Africa Workshop, who shared his reaction: "Receiving this award is a tremendous honor and a wonderful recognition of the collaborative spirit behind ISSX Africa. We are proud of the connections, conversations, and opportunities the workshop created for scientists across Africa and around the world. Thank you to everyone who helped make this initiative possible."

This recognition belongs to our scientific community, whose dedication continues to expand ISSX's impact worldwide. Thank you for being part of this achievement!

09/15/2026

Upcoming ISSX Webinar! Evaluation of Inflammatory Effect on Renal Drug Transporter Expression Using Human Kidney Biopsies and 3D-RPTECs

This webinar will explore the impact of inflammation on renal drug transporter expression and activity, focusing on OAT1 and OAT3. Using findings from human kidney biopsies and three-dimensionally cultured human proximal tubular epithelial cells (3D-RPTECs), the presentation will examine how inflammatory cytokines may contribute to altered renal drug handling in patients with renal impairment.
🔗 Register here: https://learn.issx.org/products/evaluation-of-inflammatory-effect-on-renal-drug-transporter-expression-using-human-kidney-biopsies-and-3d-rptecs
📅 Date/Time: September 28, 2026 at 5:00 PM EDT

Presented by: Hiroshi Arakawa and Kunal Taskar (moderator)

09/10/2026

Join us for a series of expert-led short courses designed to deliver focused, practical learning on key topics in pharmaceutical science and regulation. Learn more about the four short courses and view the full program here: https://issxmeetings.org/2026-na/meeting-program
Register for the meeting here: https://issxmeetings.org/2026-na/register

08/25/2026

Thank you to Davide Bassani and Jeremy Jones for presenting and Dan Scotcher and William Weigel for moderating today's ISSX webinar, "Machine learning models enabling early and high-throughput prediction of ADME properties and pharmacokinetics."

The speakers provided an overview of emerging strategies transforming pharmacokinetic (PK) prediction in modern drug discovery and explored how high-throughput physiologically based pharmacokinetic (HT-PBPK) modelling, combined with machine learning, enables rapid, structure-driven prediction of PK properties, reducing reliance on experimental data in early discovery.

This webinar recording, along with many others, can be found in the ISSX learning center: https://learn.issx.org/webinars

08/06/2026

Just one week remains! The August 13 deadline is quickly approaching for two important ISSX opportunities:

ISSX Award Nominations – Help recognize colleagues whose scientific achievements and service have made an impact on the xenobiotics community. Nominate a colleague: https://www.issx.org/page/Nominations

ISSX Fellowship for Minority Scientists – Early-career minority scientists studying xenobiotics are encouraged to apply for this fellowship, which includes complimentary registration for the 2026 North American ISSX Meeting, a travel stipend, three years of ISSX membership, a $1,500 honorarium, and more. Learn more: https://www.issx.org/page/issxfellowshipaward

07/30/2026

Share your latest research with the global scientific community! We are now accepting late breaking abstract submissions for the 27th North American Meeting taking place in San Francisco, California, USA, October 11 - 14. We encourage submissions from all those involved in the fields of:
• Drug metabolism and transport
• Pharmacokinetics
• Modelling and simulation
• Pharmacology
• Toxicology
• and other related disciplines
Learn more and submit your late breaking abstract: https://issxmeetings.org/2026-na/call-for-abstracts

07/28/2026

In his second message as ISSX President, Mike Zientek reflects on the success of the 16th European ISSX Meeting, from the conference theme and thought-provoking debate session to the awards ceremony and the lasting impact of Dr. Malcolm Rowland on the ADME research community.

He also looks ahead to an exciting future for ISSX, with upcoming North American and Asia Pacific meetings, new workshops in development, and more opportunities to connect the Xenobiotic community.

Read the full President's Message: https://www.issx.org/news/731749/ISSX-Presidents-Message-July-23-2026.htm

07/22/2026

ISSX featured article: Microfluidic liver-chip to predict clinical drug-drug interaction net effects for precipitant drugs with dual CYP3A4 inhibition and induction potential
🔗Read the article here: https://dmd.aspetjournals.org/article/S0090-9556(26)00628-8/abstrac
Authors: Lina Mettler, Justine Badée, Felix Huth, Christian Lohasz, Johanna Alm, Judith Streckfuss, Hilmar Schiller, Peter Loskill, Birk Poller, Julia Riede

07/16/2026

We are proud to share that ISSX has been selected as a recipient of the 2026 Power of Associations Summit Award: the highest honor presented by the American Society of Association Executives (ASAE).

ISSX was recognized for ISSX Africa: Transforming Science, Connecting Worlds, an initiative that reflects our commitment to advancing xenobiotics research through global collaboration, education, and scientific exchange.

This recognition belongs to our entire community, whose dedication continues to expand the impact of ISSX around the world. Thank you for being part of this achievement!

Address

3502 Woodview Trace, Suite 300
Washington D.C., DC
46268

Opening Hours

Monday	9am - 5pm
Tuesday	9am - 5pm
Wednesday	9am - 5pm
Thursday	9am - 5pm
Friday	9am - 5pm
Saturday	9am - 5pm
Sunday	9am - 5pm

Website

http://www.issx.org/

Alerts

Be the first to know and let us send you an email when International Society for the Study of Xenobiotics posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Thelma D. Jones Breast Cancer Fund
400 I Street, SW

Want your organization to be the top-listed non profit organization in Washington D.C.?